Katherine A. Janeway

Also affiliated with Harvard University, Center for Cancer and Blood Disorders, Dana-Farber Cancer Institute, Dana-Farber/Boston Children's Cancer and Blood Disorders Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.4Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Papers

Driven by 40 papers — median percentile 48. Top paper: “Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group”.

Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group

Journal of Clinical Oncology(2023)10.1200/jco.22.01815

N/A

1.7DataRank · unranked

89 citations

Mark Krailo, Julia Glade Bender, Allen Buxton, Nadia N. Laack, R. Lor Randall +20 more

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

Nature Cancer(2024)10.1038/s43018-024-00749-6

N/A

1.5DataRank · unranked

87 citations

Shoba A. Navai, Christopher DeRenzo, Sujith K. Joseph, Khaled Sanber, Meng‐Fen Wu +32 more

Gene Fusions Create Partner and Collateral Dependencies Essential to Cancer Cell Survival

Cancer Research(2021)10.1158/0008-5472.can-21-0791

N/A

1.0DataRank · unranked

27 citations

Bo Kyung A. Seong, Jett Crowdis, Jake R. Conway, Neekesh V. Dharia, Saif Alimohamed +17 more

Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3009

N/A

0.518DataRank · unranked

16 citations

Amit J. Sabnis, Paul M. Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf214

Top 42%

0.448DataRank

Top 42%7 citations

Subhashini Jagu, Malcolm A. Smith, John Shern, Douglas S. Hawkins, Elaine R. Mardis +26 more

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer

Nature Communications(2024)10.1038/s41467-024-49944-0

Top 46%

0.400DataRank

Top 46%8 citations

Hersh Gupta, Abigail Ward, Yvonne Li, Duong Doan, Alyaa Al‐Ibraheemi +28 more

Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G

The Oncologist(2024)10.1093/oncolo/oyae119

N/A

0.363DataRank · unranked

7 citations

AeRang Kim, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research

JCO Clinical Cancer Informatics(2023)10.1200/cci.23.00104

Top 58%

0.273DataRank

Top 58%4 citations

Qinbo Zhou, Lauren Furman-Cline, Xian Cheng, Danni Luo, Hongyin Lai +21 more

Update for NCI-COG Pediatric MATCH: Active trial cohorts for children, adolescents and young adults with refractory cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps10071

Top 59%

0.257DataRank

Top 59%3 citations

Katherine A. Janeway, Theodore W. Laetsch, Meredith S. Irwin, Elizabeth Alva, Christine A. Pratilas +14 more

Tazemetostat in patients with tumors with alterations in EZH2 or the SWI/SNF complex: Results from NCI-COG Pediatric MATCH trial Arm C (APEC1621C).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10009

N/A

0DataRank · unranked

21 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Long-term outcomes in patients with localized Ewing sarcoma treated with interval-compressed chemotherapy: A long-term follow-up report from Children’s Oncology Group study AEWS0031.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11505

N/A

0DataRank · unranked

6 citations

Mark Krailo, Allen Buxton, Bruce Pawel, John H. Healey, Odion Binitie +10 more

Germline predisposition to pediatric Ewing sarcoma is uniquely characterized by inherited pathogenic variants in DNA damage repair genes

medRxiv(2022)10.1101/2022.01.07.22268685

N/A

0DataRank · unranked

0 citations

Sabrina Y. Camp, Seunghun Han, Jill K. Jones, Schuyler O’Brien, Erin L. Young +11 more

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad085

N/A

0DataRank · unranked

95 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

Children's Oncology Group's 2023 blueprint for research: Bone tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30583

N/A

0DataRank · unranked

19 citations

Patrick J. Grohar, Elyssa Rubin, Odion Binitie, Mark Krailo, Jessica L. Davis +3 more

Innovations in Cancer Treatment of Children

PEDIATRICS(2023)10.1542/peds.2023-061539

N/A

0DataRank · unranked

19 citations

Allison E. Guimera, Katherine A. Janeway, Kelly M. Bailey, L. Jay Helms

Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30643

N/A

0DataRank · unranked

6 citations

Abigail Ward, Yvonne Y. Li, Lorena Lazo de la Vega, Anwesha Nag, Suzanne J. Forrest +7 more

Erdafitinb in patients with FGFR-altered tumors: Results from the NCI-COG Pediatric MATCH trial arm B (APEC1621B).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10007

N/A

0DataRank · unranked

20 citations

Alexander J. Chou, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

PEPN1924, a phase 2 study of trastuzumab deruxtecan (DS-8201a, T-DXd) in adolescents and young adults with recurrent HER2+ osteosarcoma: A children’s oncology group pediatric early-phase clinical Trial Network study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11527

N/A

0DataRank · unranked

11 citations

Katherine A. Janeway, Charles G. Minard, David Hall, Brian D. Crompton, Alexander J. Lazar +8 more

Palbociclib in solid tumor patients with genomic alterations in the cyclin D-CDK4/6-INK4a-Rb pathway: Results from NCI-COG pediatric MATCH trial Arm I (APEC1621I).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10006

N/A

0DataRank · unranked

4 citations

Rajen Mody, Joel M. Reid, Jin Piao, Lauren Saguilig, Todd A. Alonzo +14 more

Evaluation of local control strategies on patterns of treatment failure in patients with localized ewing sarcoma treated on AEWS1031: A report from the children’s oncology group.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11529

N/A

0DataRank · unranked

2 citations

Odion Binitie, Mark Krailo, Allen Buxton, Daniel J. Indelicato, Alexandra K. Callan +12 more

Autologous HER2-specific CAR T-cells after lymphodepletion for advanced sarcoma

Research Square(2023)10.21203/rs.3.rs-2409436/v1

N/A

0DataRank · unranked

0 citations

Shoba A. Navai, Christpher DeRenzo, Sujith K. Joseph, Khaled Sanber, Meng‐Fen Wu +28 more

Engagement of patient participation in genomics research by the Osteosarcoma and Leiomyosarcoma Count Me In Projects of the Cancer Moonshot funded PE-CGS Network.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11588

N/A

0DataRank · unranked

0 citations

Diane M. Diehl, Carrie Cibulskis, Priscilla Merriam, Maeve Smart, Jordan Doucette +15 more

Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30652

N/A

0DataRank · unranked

0 citations

Kevin X. Liu, A. Lindsay Frazier, Allison F. O’Neill, Katherine A. Janeway, Steven G. DuBois +2 more

Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children’s Oncology Group Bone Tumor Committee Consensus Statement

Journal of the National Comprehensive Cancer Network(2024)10.6004/jnccn.2024.7063

N/A

0DataRank · unranked

9 citations

Alyaa Al‐Ibraheemi, Jessica L. Davis, C. Matthew Hawkins, Brian T. Craig, Roshni Dasgupta +26 more

Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children’s Oncology Group report

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae103

N/A

0DataRank · unranked

6 citations

Ruxu Han, Mark Krailo, David S. Shulman, Brent R. Weil, Christopher B. Weldon +12 more

Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

UNC Libraries(2024)10.17615/xykw-ba83

N/A

0DataRank · unranked

1 citations

Riyue Bao, Meenakshi Hegde, Zeid Nawas, Rikhia Chakraborty, Birju Mehta +32 more

Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group

Pediatric Blood & Cancer(2025)10.1002/pbc.31820

N/A

0DataRank · unranked

5 citations

Alexandra K. Callan, Safia K. Ahmed, Mark Krailo, Natalie DelRocco, Allen Buxton +14 more

Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf083

N/A

0DataRank · unranked

4 citations

Kathleen Montgomery, Adam DuVall, Michael Roth, Mark Krailo, Michelle M. Nuño +13 more

Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children’s Oncology Group

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.11.010

N/A

0DataRank · unranked

1 citations

Odion Binitie, Mark Krailo, Daniel J. Indelicato, Alexandra K. Callan, Natalie DelRocco +14 more

Supporting Participant Engagement in Cancer Genomics Research in Rare Cancers: A Qualitative Study of Patients, Caregivers, and Advocates

Cancer Control(2025)10.1177/10732748251364041

N/A

0DataRank · unranked

0 citations

Lily Weber, Lauren Fisher, Andrew Khalaj, Eirian Siegal-Botti, Diane M. Diehl +4 more

Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3089

N/A

0DataRank · unranked

57 citations

Alyaa Al‐Ibraheemi, Duong Doan, Abigail Ward, Catherine Clinton, Juan Putra +11 more

A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2885

N/A

0DataRank · unranked

0 citations

Alexander J. Chou, Allen Buxton, Joel M. Reid, Michael S. Isakoff, Lisa M. Kopp +12 more

Phase II study of antidisialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma (AOST1421): A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10508

N/A

0DataRank · unranked

18 citations

Mark Krailo, Allen Buxton, Paul R. Hutson, J. Wade Davis, Katherine A. Janeway +3 more

Maximum tumor dimension and tumor volume as prognostic factors in patients with newly diagnosed localized Ewing sarcoma (ES)- a report from the Children’s Oncology Group (COG).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11529

N/A

0DataRank · unranked

4 citations

Allen Buxton, Steven G. DuBois, Dian Wang, Nadia N. Laack, Kenneth L. Brown +15 more

PARP inhibition in Ewing sarcoma: impact of germline DNA damage repair defects and activation of immunoregulatory pathways

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.18.304238

N/A

0DataRank · unranked

1 citations

Rosemarie E. Venier, Elina Mukherjee, Claire M. Julian, Jessica D. Daley, Nathanael G. Bailey +10 more

Updated outcomes for patients with completely resected pulmonary recurrent osteosarcoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10023

N/A

0DataRank · unranked

3 citations

Mark Krailo, Ruxu Han, Allen Buxton, Damon R. Reed, Richard Görlick +5 more

Factors impacting enrollment on NCI-COG Pediatric MATCH trial treatment protocols.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10007

N/A

0DataRank · unranked

3 citations

Katherine A. Janeway, David R. Patton, Jennifer Lee, Brent Coffey, P. Mickey Williams +16 more

Selumetinib in patients with tumors with MAPK pathway alterations: Results from Arm E of the NCI-COG pediatric MATCH trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10008

N/A

0DataRank · unranked

2 citations

Olive S. Eckstein, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Germline predisposition to pediatric Ewing sarcoma is characterized by inherited pathogenic variants in DNA damage repair genes

The American Journal of Human Genetics(2022)10.1016/j.ajhg.2022.04.007

N/A

0DataRank · unranked

49 citations

Sabrina Y. Camp, Seunghun Han, Jill K. Jones, Hoyin Chu, Schuyler O’Brien +12 more

BRCA1-Associated RING Domain-1 (BARD1) Loss and GBP1 Expression Enhance Sensitivity to DNA Damage in Ewing Sarcoma

Cancer Research Communications(2022)10.1158/2767-9764.crc-21-0047

N/A

0DataRank · unranked

16 citations

Jessica D. Daley, Elina Mukherjee, Rosemarie E. Venier, Claire M. Julian, Nathanael G. Bailey +11 more

Katherine A. Janeway

Indexed papers

Top data-sharing exemplar

Papers